Literature DB >> 6546907

PHARM--an interactive graphic program for individual and population pharmacokinetic parameter estimation.

R Gomeni.   

Abstract

This paper describes a new computer program PHARM to estimate individual or population pharmacokinetic parameters in nonlinear models. PHARM is an interactive program which uses graphic facilities to display data and results. The structural model can be defined using differential or integrated equations. The user can also define an error model associated with experimental data. The nonlinear mixed effect model is used to estimate the mean population parameters and their interindividual variability. The maximum likelihood and Bayesian criteria are used to estimate simultaneously the error and structural model parameters.

Mesh:

Substances:

Year:  1984        PMID: 6546907     DOI: 10.1016/0010-4825(84)90017-9

Source DB:  PubMed          Journal:  Comput Biol Med        ISSN: 0010-4825            Impact factor:   4.589


  46 in total

1.  Pharmacokinetics and inflammatory fluid penetration of sparfloxacin.

Authors:  J H Johnson; M A Cooper; J M Andrews; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

2.  Quantification of tissue distribution of antibiotics by kinetic hysteresis analysis.

Authors:  U Ganzinger; K Neumann
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  Kinetics and hemodynamic effects of intravenous nicardipine modified by previous propranolol oral treatment.

Authors:  P Rocha; M Guerret; D David; X Marchand; J C Kahn
Journal:  Cardiovasc Drugs Ther       Date:  1990-12       Impact factor: 3.727

4.  Inter- and intraindividual variability in the concentration-effect (sedation) relationship of flunitrazepam.

Authors:  A Grahnén; P Wennerlund; B Dahlström; S A Eckernäs
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

5.  Doxorubicin and doxorubicinol: intra- and inter-individual variations of pharmacokinetic parameters.

Authors:  J M Jacquet; F Bressolle; M Galtier; M Bourrier; D Donadio; J Jourdan; J F Rossi
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

6.  Pharmacokinetics of intravenous and oral chlordesmethyldiazepam in patients on regular haemodialysis.

Authors:  J Sennesael; D Verbeelen; L Vanhaelst; R Pirola; S R Bareggi
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

7.  Pharmacokinetics and tissue penetration of ceftibuten.

Authors:  R Wise; K Nye; P O'Neill; M Wostenholme; J M Andrews
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

8.  Pharmacokinetics and penetration into inflammatory fluid of trovafloxacin (CP-99,219).

Authors:  R Wise; D Mortiboy; J Child; J M Andrews
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

9.  Doxycycline carrageenate--an improved formulation providing more reliable absorption and plasma concentrations at high gastric pH than doxycycline monohydrate.

Authors:  A Grahnén; B Olsson; G Johansson; S A Eckernäs
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

10.  Clinical pharmacokinetics of intravenous and oral 9-amino-1,2,3,4-tetrahydroacridine, tacrine.

Authors:  P Hartvig; H Askmark; S M Aquilonius; L Wiklund; B Lindström
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.